Page last updated: 2024-08-24

1,2-dithiol-3-thione and Allergic Encephalomyelitis

1,2-dithiol-3-thione has been researched along with Allergic Encephalomyelitis in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brown, DA; Kuo, PC; Paraiso, HC; Scofield, BA; Wang, PY; Yen, JH; Yu, IC1
Brown, DA; Chang, FL; Kuo, PC; Scofield, BA; Wang, PY; Yen, JH; Yu, IC1

Other Studies

2 other study(ies) available for 1,2-dithiol-3-thione and Allergic Encephalomyelitis

ArticleYear
Dithiolethione ACDT suppresses neuroinflammation and ameliorates disease severity in experimental autoimmune encephalomyelitis.
    Brain, behavior, and immunity, 2018, Volume: 70

    Topics: Animals; Central Nervous System; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Female; Macrophage Activation; Mice; Mice, Inbred C57BL; Microglia; Multiple Sclerosis; Myelin Sheath; Th1 Cells; Th17 Cells; Thiones; Thiophenes

2018
3H-1,2-dithiole-3-thione as a novel therapeutic agent for the treatment of experimental autoimmune encephalomyelitis.
    Brain, behavior, and immunity, 2016, Volume: 57

    Topics: Animals; Anti-Inflammatory Agents; Dendritic Cells; Encephalomyelitis, Autoimmune, Experimental; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microglia; Th1 Cells; Th17 Cells; Thiones; Thiophenes

2016